Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients

Inclusion Criteria: * Have a clinical diagnosis of CHC established on the basis of a detectable viral load as measured by a serum HCV RNA test at least 6 months before and during the screening period. * Age 20 to 69 years * Have compensated liver disease results on screening laboratory assessment Exclusion Criteria: * Evidence of decompensated liver disease and/or liver cirrhosis. * Body weight \< 50 kg. * A history of immunologically mediated disease. * A history or other clinical evidence of interstitial lung disease